Govt Job: For Pharmacists under Central Government Health Scheme

For the last six decades Central Government Health Scheme is providing comprehensive medical care to the Central Government employees and pensioners enrolled under the scheme.

In fact CGHS caters to the healthcare needs of eligible beneficiaries covering all four pillars of democratic set up in India namely Legislature, Judiciary, Executive and Press.

Post : Pharmacist

Advertisement for engaging retired Govt, employee for following Group C posts, who had retired from Central Govt., State Govt., Public Sector Undertaking, Local Govt, bodies for short term contractual engagement under CGHS, Lucknow for A.D. Office, Polyclinic & Wellness Centre at Lucknow, Agra, Bareilly & Gorakhpur, as per terms and conditions given below.

Pharmacist (Allopathic) – 07 (Lucknow-5, Gorakhpur-1, Bareilly-1)

Pharmacist (Ayurvedic) – 01(Lucknow Wellness Centre)

Pharmacist (Homoeopathic) – 01 (Lucknow Wellness Centre)

Pharmacist ( Unani) – 02  (Lucknow Wellness Centre)

Remuneration (per month) : Rs 25500/-, or “last pay drawn minus pension before commutation,” whichever is less.

Age : Not exceeding 64 years on the date publication.

Duration of appointment : Contractual appointment for a period of 180 days or till the regular appointment, or attaining the age of 65 years, whichever is earlier.

Place of Posting : The selected candidates will be posted in A.D Office, Polyclinic & Wellness Centre at Lucknow, Agra, Bareilly & Gorakhpur, as per need, under the control of The Additional Director, CGHS Lucknow.

Preference :1. Preference shall be given to the candidates belonging to concerned city.
Candidate having knowledge of computers.

Terms & Conditions
(a) Remuneration will commence from the date of reporting for duty at the place of posting.

(b) Tax will be deducted at source as per rules.

(c) The appointee shall not be entitled to any other benefit granted to at regular CGHS employee like PF, Pension, Gratuity, Medical attendance, Seniority, Promotion, and LTC etc.

(d) The appointee will not accept any other employment during the engagement under CGHS Lucknow.

(e) Contractual employee will be eligible for 1.5 days paid leave for each completed month of service. Accumulation of leave beyond a calendar year will not be allowed.

(g) The applicant will have to produce his certificates in original (along with one set of self attested photocopies) for verification, at the time of personal interview.

(h) Additional Director, CGHS, Lucknow has the privilege to terminate the services at any time, without assigning any reason.

Related Posts

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

New Delhi: In a major crackdown on the sale of expired and substandard products, the Central Range team of Delhi Police Crime Branch has arrested one person and seized nearly…

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

Washington:  On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg